Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) Director Jeri Williams sold 110 shares of Axon Enterprise stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $400.00, for a total transaction of $44,000.00. Following the completion of the sale, the director now directly owns 1,934 shares in […]

ICU Medical, Inc. (NASDAQ:ICUI – Get Free Report) CEO Vivek Jain sold 12,000 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares […]

Premier, Inc. (NASDAQ:PINC – Get Free Report) CEO Michael J. Alkire sold 1,264 shares of the business’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $20.01, for a total transaction of $25,292.64. Following the sale, the chief executive officer now directly owns 558,143 shares in the […]

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) Director Rosty Raykov sold 2,431 shares of Fennec Pharmaceuticals stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $4.94, for a total value of $12,009.14. Following the sale, the director now directly owns 66,432 shares in the company, valued […]

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) CFO Cecilia Jones sold 2,542 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $49.03, for a total value of $124,634.26. Following the sale, the chief financial officer now owns 20,158 shares of […]

BlackLine, Inc. (NASDAQ:BL – Get Free Report) CFO Mark Partin sold 5,648 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $53.00, for a total transaction of $299,344.00. Following the sale, the chief financial officer now owns 226,844 shares in the company, valued at […]

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) CFO Marc Wilson sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $51.11, for a total transaction of $1,277,750.00. Following the completion of the transaction, the chief financial officer now directly […]

Coinbase Global, Inc. (NASDAQ:COIN) insider Paul Grewal sold 10,000 shares of the business’s stock in a transaction on Wednesday, September 25th. The stock was sold at an average price of $170.10, for a total value of $1,701,000.00. Following the transaction, the insider now directly owns 74,956 shares of the company’s stock, valued at approximately $12,750,015.60. […]